MetaCap

Prime Medicine Statistics

NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.55-0.29 (-7.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Prime Medicine by the numbers

Prime Medicine has a market capitalization of $791.6 million based on 222.99M shares outstanding. With trailing EPS of $-0.97, Prime Medicine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.0% below its 50-day average and 1.2% above its 200-day average.

Average daily trading volume is 4.64M shares, or about $16.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PRME valuation vs. peer median

PRME compared with the median of 8 peer companies
MetricPRMEPeer medianDifference
Market cap$791.62M$759.09M+4%
Avg. volume4.64M842.23K+451%

Peer median across 8 companies: MGTX, BBTX, ODTX, GLUE, AURA, IMTX, SLDB, ATTO.

Valuation

Market cap
$791.62M
Price / sales (latest FY)
170.90
EPS (TTM)
$-0.97

Price and trading

Previous close
3.84
Open
3.70
Day range
3.49 – 3.93
52-week range
2.67 – 5.91
52-week change
-2.20%
Beta
—
Volume
6.13M

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
791.62M
Forward Pe
-4.30
Eps
-0.97
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.91
Week52 Low
2.67
Avg Volume
4.64M
Shares Outstanding
222.99M
Ma50
3.74
Ma200
3.51
Earnings Date
Nov 12, 2026
Pct From52w High
-39.93%
Pct From52w Low
32.96%

Related